GEMINA LABORATORIES LTDGEMINA LABORATORIES LTDGEMINA LABORATORIES LTD

GEMINA LABORATORIES LTD

No trades
See on Supercharts

GLAB fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Gemina Laboratories Ltd. engages in the development of biotechnology in the In Vitro Diagnostics and human wellness monitoring market under the name “Gemina Labs.” Its products include LEGIO X, LEGIO XI, Respiratory Syncytial Virus, and Tuberculosis. The company was founded by Stephen John Davies and Robert Crandall Greene on October 10, 2017 and is headquartered in Burnaby, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
GLAB has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company